BMS-184476 in Treating Patients With Advanced Solid Tumors
NCT00003705
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG:
BMS-184476
Sponsor
San Antonio Cancer Institute